Humana and S&P 500 Performance During 2007-08 Crisis HUM stock declined from $71 in September 2007 (pre-crisis peak) to $24 in March 2009 (as the markets bottomed out).

Humana Inc.’s stock was up 2% Friday after three straight sessions of declines, but investors paying attention to the performance of its bonds on Thursday may have had something of a heads-up on ...

The company's recent financial performance has been mixed. While Humana has maintained a solid market position with a healthy free cash flow yield of 8% and 14 consecutive years of dividend ...

Humana is displaying robust revenue growth and expanding margins, driven by strong demand in core markets. Read more on why ...

This was the stock's second consecutive day of losses.

The lower rating won’t affect Humana’s performance until 2026, ... Humana’s logo at the New York Stock Exchange on Dec. 6, when the company traded at close to $500 a share.

Shares of Humana (HUM) are plummeting after the company disclosed a lower performance rating for its largest Medicare Advantage plan that could pose a threat to its revenue in 2026. Catalysts ...

Humana (NYSE:HUM) has had a great run on the share market with its stock up by a significant 13% over the last month. Given that stock prices are usually aligned with a company's financial ...

Humana and S&P 500 Performance During 2007-08 Crisis HUM stock declined from $71 in September 2007 (pre-crisis peak) to $24 in March 2009 (as the markets bottomed out).

Humana Inc.’s stock was up 2% Friday after three straight sessions of declines, but investors paying attention to the performance of its bonds on Thursday may have had something of a heads-up on ...